NAVAMEDIC ASA: årsregnskap 2023 vs 2022
Weaker earnings
approved 2024-04-30; registry 2024-07-29; journal 2024 618986
Summary
What changed
Comparing Årsregnskap 2023 with 2022 for NAVAMEDIC ASA. Revenue 46.25m NOK → 47.63m NOK (+3.0%). Net result +40.97m NOK → +3.30m NOK. Equity 212.8k NOK → 201.62m NOK.
On the constructive side: revenue rose; equity strengthened; cash rose. Pressures included: operating result weakened; net result weakened; current ratio dropped below 1×.
Also worth watching: payroll increased. All figures are taken from the published annual accounts for NAVAMEDIC ASA.
At a glance
Scorecard
What improved
-
↑
Revenue rose
Operating income / revenue moved from 46.25m NOK to 47.63m NOK (+3.0% YoY). Calculated
-
↑
Equity strengthened
Book equity 212.8k NOK → 201.62m NOK (equity ratio 0.1% → 36.5%). Calculated
-
↑
Cash rose
Bank deposits 6.01m NOK → 7.81m NOK (+30.0% YoY). Calculated
-
↑
Owners injected capital
Paid-in equity rose 203.16m NOK → 205.42m NOK (+2.26m NOK). Reported fact
What deteriorated
-
↓
Operating result weakened
Operating result -9.74m NOK → -33.66m NOK (op. margin -21.0% → -70.7%). Calculated
-
↓
Net result weakened
Net result +40.97m NOK → +3.30m NOK (net margin 88.6% → 6.9%). Calculated
-
↓
Current ratio dropped below 1×
Current ratio 7.48× → 0.32× — short-term liabilities now exceed liquid/current assets on the published lines. Calculated
Things to notice
-
·
Payroll increased
Salary cost 30.52m NOK → 36.83m NOK (66% → 77% of revenue). Calculated